The 2025 financial year

Dr Luc Schultheiss, how did Endress+Hauser perform in the past year?

Our financial figures for 2025 are heavily influenced by the integration of SICK gas analyzers and flowmeters into our business under the strategic partnership with the German sensor specialist. This expanded product offering has driven significant growth in the Endress+Hauser Group’s sales. In constant currency terms, sales in our traditional core business areas were likewise solid. Translated into euros, they were marginally down year on year. These currency effects also impacted our bottom line.

Overall, we performed well in what was a challenging business environment. The figures for five out of our seven strategic industries were positive, and we achieved good growth in many markets worldwide, including the US. On the other hand, performance was very weak in certain countries – China and Germany included. Among the many positive signs from the past year is the increase in incoming orders, which augurs well for the future. In 2026, we will continue taking advantage of opportunities for growth wherever they present themselves.